174 related articles for article (PubMed ID: 1970224)
21. The use of low-dose neuroleptics in the treatment of "schizo-obsessive" patients.
Schulz SC
Am J Psychiatry; 1986 Oct; 143(10):1318-9. PubMed ID: 2876650
[No Abstract] [Full Text] [Related]
22. Successful fluvoxamine treatment of a case of refractory obsessive-compulsive disorder.
Solyom L; Solyom CA
Can J Psychiatry; 1990 Nov; 35(8):696-8. PubMed ID: 2126485
[TBL] [Abstract][Full Text] [Related]
23. Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.
Heiden A; de Zwaan M; Frey R; Presslich O; Kasper S
J Psychiatry Neurosci; 1998 May; 23(3):179-80. PubMed ID: 9595892
[No Abstract] [Full Text] [Related]
24. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.
McDougle CJ; Goodman WK; Leckman JF; Holzer JC; Barr LC; McCance-Katz E; Heninger GR; Price LH
Am J Psychiatry; 1993 Apr; 150(4):647-9. PubMed ID: 8465885
[TBL] [Abstract][Full Text] [Related]
25. Seizures induced by combined levomepromazine-fluvoxamine treatment.
Grinshpoon A; Berg Y; Mozes T; Mester R; Weizman A
Int Clin Psychopharmacol; 1993; 8(1):61-2. PubMed ID: 8473723
[TBL] [Abstract][Full Text] [Related]
26. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
27. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].
Salmerón JM; Alcántara AG; Barcia D
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):399-402. PubMed ID: 9972593
[TBL] [Abstract][Full Text] [Related]
28. Fluvoxamine in the treatment of panic disorder with obsessive-compulsive symptoms.
Servant D; Bailly D; Parquet PJ
Am J Psychiatry; 1988 Sep; 145(9):1174-5. PubMed ID: 3137830
[No Abstract] [Full Text] [Related]
29. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.
Goodman WK; Price LH; Rasmussen SA; Delgado PL; Heninger GR; Charney DS
Arch Gen Psychiatry; 1989 Jan; 46(1):36-44. PubMed ID: 2491940
[TBL] [Abstract][Full Text] [Related]
30. Serotonin and treatment in obsessive-compulsive disorder.
March JS; Gutzman LD; Jefferson JW; Greist JH
Psychiatr Dev; 1989; 7(1):1-18. PubMed ID: 2508084
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
Yoshimura R; Kaneko S; Shinkai K; Nakamura J
Psychiatry Clin Neurosci; 2006 Jun; 60(3):389-93. PubMed ID: 16732759
[TBL] [Abstract][Full Text] [Related]
32. Compulsive personality as predictor of response to serotoninergic antidepressants.
Ansseau M; Troisfontaines B; Papart P; von Frenckell R
BMJ; 1991 Sep; 303(6805):760-1. PubMed ID: 1932937
[No Abstract] [Full Text] [Related]
33. Obsessive-compulsive disorder.
March JS; Johnston H; Greist JH
Am Fam Physician; 1989 May; 39(5):175-82. PubMed ID: 2497627
[TBL] [Abstract][Full Text] [Related]
34. Serotonin selectivity for obsessive compulsive and panic disorders.
Montgomery SA; Bullock T; Fineberg N
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
[No Abstract] [Full Text] [Related]
35. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.
Lombroso PJ; Scahill L; King RA; Lynch KA; Chappell PB; Peterson BS; McDougle CJ; Leckman JF
J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1147-52. PubMed ID: 7559308
[TBL] [Abstract][Full Text] [Related]
36. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder.
Delgado PL; Goodman WK; Price LH; Heninger GR; Charney DS
Br J Psychiatry; 1990 Nov; 157():762-5. PubMed ID: 2126219
[TBL] [Abstract][Full Text] [Related]
37. Concomitant obsessive-compulsive disorder and schizotypal personality disorder.
Jenike MA; Baer L; Minichiello WE; Schwartz CE; Carey RJ
Am J Psychiatry; 1986 Apr; 143(4):530-2. PubMed ID: 3953896
[TBL] [Abstract][Full Text] [Related]
38. [The treatment of the resistant obsessive-compulsive disorder: an update].
Crespo Facorro B; Gomez-Hernández R
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(1):61-9. PubMed ID: 9133159
[TBL] [Abstract][Full Text] [Related]
39. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
den Boer JA; Westenberg HG; Kamerbeek WD; Verhoeven WM; Kahn RS
Int Clin Psychopharmacol; 1987 Jan; 2(1):21-32. PubMed ID: 3117876
[TBL] [Abstract][Full Text] [Related]
40. Risperidone as monotherapy for a patient with obsessive compulsive disorder comorbid with schizoaffective disorder: a case report.
Chiou YJ; Lin PY; Lee Y
Clin Neuropharmacol; 2015; 38(3):114-6. PubMed ID: 25970281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
